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About 50% of selective IgA-deficient individuals have very high antibody titers to 
bovine serum proteins, presumably because of the continuous excessive absorption of 
dietary antigens from the gastrointestinal tract into the blood stream (1, 2). Most of 
these individuals also have high levels of circulating immune complexes in their sera, 
and we have shown (2-4)  that these complexes  contain bovine proteins.  In experi- 
mental systems,  immunization with antigen-antibody complexes  is a  very effective 
means of producing anti-idiotypic antibodies (5). From the network theory of im- 
munoglobulin regulation (6) one might expect that such autoantii?odies  to the variable 
regions  of antibovine protein  antibodies would be  found in  these human sera.  It 
would also seem probable that these autoantibodies would be important components 
of circulating immune complexes.  This report  describes  the isolation of auto-anti- 
idiotypic antibodies to the F(ab')2  of anticasein purified from the sera of two IgA 
deficient subjects and these experiments demonstrate by antigen blocking that most 
of these autoantibodies bind anticasein in the region of the casein binding site. In 
addition, these studies suggest that anti-idiotypic antibodies do participate in in vivo 
immune complex formation, competing with dietary casein antigen for binding sites 
on the anticasein antibody. 
Materials and Methods 
Sera and Immunoglobulin  Fractions.  The sera of two healthy IgA-deficient subjects, A and B, 
were used in these studies; both had previously been identified as having large amounts of IgG 
1  anti-casein antibodies by an enzyme-linked immunosorbant  assay (ELISA)  (3). Two myeloma 
proteins, IgG1 (HA)  and IgG1 (GU) and the IgG fraction of pooled human gamma globulin 
("Gamastan", Cutter Laboratories, Berkeley, CA) were purified by passage over DEAE cellulose 
(Bio-Rad Laboratories, Richmond, CA) equilibrated in 0.01 M  Na phosphate buffer pH 7.1. 
Aliquots of both myeloma proteins and the pooled gamma globulin were pepsin digested (7) 
for 20 h at room temperature and the F(ab')2 of each isolated by gel filtration on Sephadex 
G150 (Pharrnacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N  J). 
Affinity  Chromatography.  Anticasein antibodies were  isolated  from  75  ml  of serum  from 
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subject A and 85 ml from subject B by passage of a well-dialyzed, 50%-saturated (NH4)2SO4 
precipitated IgG-containing  fraction of serum on Sepharose 4B (Pharmacia Fine Chemicals) to 
which casein (ICN Nutritional Biochemicals, Cleveland, OH) had been coupled using cyanogen 
bromide (CNBr)  (8). After removal of the nonadherent fractions by passage of 5 column vol of 
phosphate-buffered saline (PBS),  the adherent fractions were etuted by 0.1  M  glycine HC1 
buffer, pH 2.7. These fractions, containing ~ 1.5 mg IgG/ml were passed over DEAE cellulose 
equilibrated in 0.01 M Na phosphate buffer pH 7.1 to purify IgG and eliminate possible traces 
of casein, which adheres to cellulose under these conditions (9). In some cases the anticasein 
fractions were also passed  over Sephadex G150 to collect fractions eluting the void volume. 1 
mg of the resulting anticasein fractions of each subject were then coupled to 2 ml of CNBr- 
activated Sepharose 4B  (8). IgG fractions of serum A and B that had not adhered to casein- 
Sepharose,  were passed on their respective anticasein columns and potential anti-anti-casein 
antibodies were eluted by the glycine buffer. These anti-anticasein antibodies were further 
purified by passage over DEAE cellulose, and then G150 Sephadex to collect  fractions eluting 
in the void volume. 
Preparation of Pepsin-digested Alkaline Phosphatase-labeled Anticasein.  An aliquot of anticasein 
antibodies of each donor were pepsin digested (7), and the F(ab')2 isolated by gel filtration on 
Sephadex G150. Antigen-specific F(ab')a of each were then isolated by repassage and elution 
from casein-Sepharose. Part  of the pepsin-treated, affinity-repurified anticasein of serum A 
and B (containing  about 150/tg IgG/ml) was then coupled to alkaline phosphatase (AP) at an 
enzyme/antibody  ratio of 1:2 (3, 10). The enzyme-antibody  conjugates used were eluted in the 
void volume of a 6 X 0.2 cm column of Uhragel ACA-22 (LKB-Produkter Brumma, Sweden). 
The preparations were made 5% in chicken ovalbumin (three-times crystallized; Sigma Chem- 
ical Co., St. Louis, MO) to block residual glutaraldehyde and eliminate nonspecifie reactions. 
Approximately 35% of the enzyme-antibody  activity of these final preparations could be bound 
specifically to Sepharose casein as determined in a separate elution study. 
Preparation of Alkaline Phosphatase-labeled Casein.  Purified sodium easeinate (10) was coupled 
to AP at an enzyme/protein ratio of 1:2 and then filtered on Uhragel ACA-22 to collect the 
aggregates eluting in the void volume. The conjugate was made 5% in chicken ovalbumin and 
used at a dilution of 1:100 in PBS-0.02% Tween-20 (Sigma Chemical Co.). 
Assays  for Anti-Anticaseins 
USING  STAPHYLOCOCCUS AUREUS.  In separate tubes, increasing amounts (from 25 to  1,600 
ng) of F(ab')2 antieasein of serum A or B were added to 600 ng of anti-anticasein  of serum A or 
B, and 200 ng of AP labeled F(ab')2 anticasein isolated from the same sera.  In other tubes 
containing both anti-anticasein and AP-anticasein, possible  inhibitors of the enzyme-labeled 
anticasein and anti-anticasein  interaction were  10  -s M casein, 1 #g of the F(ab')~ of myeloma 
proteins HA and GU, or 1/~g of F(ab')2 of pooled human gamma globulin. In addition, 1/tg 
of pepsin-digested anticasein of subject B was tested with the anti-anticasein  of subject A, and 
1.6/~g of pepsin-digested anti-casein of subject A was tested with the anti-anticasein  of subject 
B. In each tube, total volumes of 200/~1 were achieved by additions of normal saline (NS). After 
incubating  these reactants overnight at 4°C, 100/~1 of a 10% suspension of heat-killed, formalin- 
fixed Staphylococcus aureus (SA) (11) in PBS was added to each sample, After again incubating 
at 4°C for  1 h, SA pellets were washed three times in PBS containing 0.25% Tween-20 and 1 
ml of a  1 mg/ml solution of p-nitrophenyl phosphate (NPP)  (Technicon Instruments Corp., 
Tarrytown, NY)  was added  (3,  11). After 3 h  at 25°C, SA pellets were  removed by  10-rain 
centrifugation (730 g, GLC-2, Sorvall, Ivan Sorvall, Norwalk, CT), and the OD 400 nm of the 
supernatant was  read  (Beckman Acta C  iii spectrophotometer, Beckman Instruments, Inc., 
Fullerton, CA). Control samples contained no anticasein, no anti-anticasein,  no enzyme-labeled 
anticasein, or SA alone. 
USING ANTICASEIN  BOUND TO POLYSTYRENE. In a further test of tl~e interactions between anti- 
anticasein, anticasein, and casein, anticaseins (pepsin digested or intact) of subjects A and B 
were used to coat polystyrene tubes (NUNC, Copenhagen, Denmark), using 0.5 ml of a  1 /xg 
IgG/ml solution in 0.1  M  Na carbonate buffer, pH 9.6 per tube, and incubating in a  water 
bath at  37°C for  3 h  (8). After washing three times with NS-Tween-20 (0.25%), increasing 
amounts (1-100 ng) of anti-anticasein of subject A or B in PBS-0.02% Tween were incubated 
in these  tubes for 5 h  at room temperature. After washing again, 0.5  ml of the diluted AP CHARLOTTE  CUNNINGHAM-RUNDLES  713 
conjugated casein in PBS was added and the incubation continued for 16 h. After rewashing, 
1 ml ofa 1 mg/ml solution of NPP was added (3, 10), and the resulting yellow color read in a 
spectrophotometer. Control samples contained no anticasein,  or no anti-anticasein. The dilution 
of the  casein  conjugate  used  was  previously determined  in  a  preliminary experiment  by 
incubating various dilutions of this conjugate in the anticasein coated tubes.  After washing, 
NPP was added. The dilution of conjugate producing a satisfactory yellow color in a period of 
one hour was chosen for these tests. All tests were performed in duplicate. 
Trace Iodination of Anti-Anticasein.  An  aliquot  of anti-anticasein  of subject  B  was  trace 
iodinated  by tzsI (New  England  Nuclear,  Boston,  MA)  using chloramine T  (12) and  then 
extensively  dialysed  against  PBS  to  remove unbound  lzsI. The  final  specific  activity was 
calculated to be 5.0 #Ci/mg. 
SDS-Polyaco,  larnide Gel Electrophoresis.  Aliquots of the anticasein antibodies of subjects A and 
B and the [125I]anti-anticasein of subject B were reduced and subjected to electrophoresis  in 12- 
cm 5% polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS) (13). The resulting 
gels were either stained with 0.05% Coomassie blue or sliced into 2-mm slices and counted in 
a Packard Autogamma counter (Packard Instrument Co., Downers Grove, IL). 
lgG Quantitation.  Radial immunodiffusion (14) was used to determine IgG concentrations 
for levels __.2 mg, and an ELISA method (to be described separately) for IgG concentrations 
falling between 10 ng/ml and 2 mg/ml. 
Results 
The anticasein antibody preparations isolated from the serum of the two individuals 
contained ~ 1.5 mg of IgG, and the molecular weights of reduced samples analysed on 
SDS polyacrylamide gel electrophoresis were consistent with the molecular weight of 
H  and L chains of IgG (53,000 and 23,000). The final anticasein preparations had 20 
times the anticasein activity per mg IgG (as determined by ELISA) when compared 
with whole starting serum, and ~40% of the protein of these preparations adhered to 
casein Sepharose as determined in a separate elution experiment. 
The anticasein  antibodies of subjects A  and B  were used to prepare two second° 
affinity columns for the isolation of anti-anticaseins.  An iodinated,  further-reduced, 
purified  preparation  of subject  B's anti-anticasein  was  found  to  have a  molecular 
weight profile of H  and L chains of IgG on SDS-polyacrylamide gel electrophoresis. 
30-35% of the IgG in these anti-anticasein preparations of subject A and B was found 
to bind to the anticasein of the same donor. 
To test the binding of the presumptive auto-anti-idiotypic antibody to anticasein, 
two kinds of experiments were performed. In the first, increasing amounts of nonla- 
beled anticasein were introduced to increasingly prevent a limited amount of enzyme- 
labeled anticasein from binding to anti-anticasein attached to SA. Fig.  1 shows that 
the AP-conjugated F(ab')2 anticaseins of both IgA-deficient patients A  and B  (panel 
A and B) are progressively inhibited from binding to their respective anti-antibodies 
by increasing amounts of unlabeled F(ab')2 anticasein. Pepsin-treated pooled human 
gamma  globulin  or  two  IgG  myeloma  proteins  did  not  inhibit  the  binding  of 
anticaseins  to their  respective anticasein  antibodies.  Casein  (10  -3  M)  produced  an 
80% inhibition  of idiotype binding  for subject  A  and 95%  inhibition  for subject  B, 
demonstrating that most, although not all, of the idiotypic antibodies bind in or near 
the antigen binding site. The antica.sein of subject B inhibited by 43% the binding of 
subject A's anticasein to anti-anticasein; and the anticasein of subject A inhibited the 
same interaction of subject B by 34%. 
In the second assay, a  three-party reaction was established to further analyse the 
capacity of anti-anticasein to block the adherence of casein to anticasein. In Fig. 2, it 714  AUTOLOGOUS  ANTI-IDIOTYPIC  ANTIBODIES  IN  HUMAN  SERA 
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Fro.  1.  An ELISA  SA assay  demonstrates  that  increasing  amounts  of anticaseins  of subject  A 
(panel A) and subject B  (.panel  B) produce increasing inhibition of the binding of their respective 
anti-anticaseins  to  the alkaline phosphatase-labeled  anticasein  of each.  The  absorbanee  400  nm 
[abscissa]  indicates the relative  binding of the enzyme-labeled  anticasein.  Pooled  human  gamma 
globulin  and two myeloma  proteins  produced  no  inhibition  but casein  itself produced  profound 
inhibition. Moderate inhibition appears to be present when the anticasein of subject A is tested with 
the anti-anticasein of subject B (panel B), or vice versa (panel A). The control, SA alone, is indicated. 
is seen that as increasing amounts of intact anti-anticasein are added to polystyrene 
tubes  coated  with  anticasein,  progressively  less  AP-labeled  casein  is  able  to  bind. 
(Anti-anticasein and anticasein interactions of subjects A  and B  are shown in panels 
A  and  B,  respectively.)  The  results  obtained  in  these  experiments  did  not  differ 
whether pepsin-digested or intact anticaseins were used to coat the polystyrene tubes. 
Discussion 
The  antigenic  individuality  of human Ig,  a  property of the Vn  region, was  first 
described  for humans by Kunkel et  al.  (15)  and for rabbits by Oudin and Michael 
(16).  That  an  individual  may  find  regions  of his  own  IG  antigenic  and  produce 
autoantibodies (anti-idiotypes)  is the basis of the Jerne network hypothesis (6), which 
proposes that all  normal in  vivo antibody responses are balanced  by the reciprocal 
production of idiotypes and autologous anti-idiotypes. Current experimental evidence 
in  murine  models  strongly  favors  cellular  and  humoral  control  by  idiotype-anti- 
idiotype  interactions  (17-19),  but  very  few  instances  of these  activities  in  human 
systems have yet been described.  In one, a T  cell antibody with a specific suppressive 
action on the one-way mixed lymphocyte culture reaction was identified in the serum CHARLOTTE  CUNNINGHAM-RUNDLES 
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Fro.  2.  As increasing volumes  of an anti-anticasein preparation of subject A or B (panel A or B) 
are added to polystyrene tubes coated with the anticasein of the same donor, progressively  less 
binding of alkaline phosphatase-labeled  casein is permitted to occur. The relative binding is given 
by the absorbance  at 400 nm, abscissa. 
of a long-surviving renal transplant patient (20);  and in another, immune complexes 
containing a  tumor cytotoxin complex and an antiglobulin were detected in several 
normal sera  (21).  Because,  in  this  latter study,  pooled human  IgG also bound  the 
tumor-antibody complex, nonspecific antibody interactions  are difficult  to exclude. 
Possible anti-idiotypic activity has  also  been  found  in  the  IgM  fractions  of mixed 
cryoglobulins (22). 
The  experiments  of the  present  report  show  that  an  autologous  anti-anticasein 
antibody can  be isolated  from the  sera of IgA-deficient individuals.  Because  these 
anti-anticaseins could bind to either pepsin treated or intact anti-casein, the observed 
binding of idiotype and anti-idiotype is not due to the release of "hidden  determi- 
nants"  due  to  pepsin  treatment  (23).  Binding  of this  nature  must  be excluded  in 
experiments utilizing pepsin-treated immunoglobulins. To insure that the final prep- 
arations were free of casein  and/or  casein-anticasein  complexes that  might  behave 
similarly in  the  assay systems used  for anti-anticasein,  the  potential  anti-idiotypic 
antibodies were passed over Sepharose-casein, DEAE cellulose, and then G150 Seph- 
adex. The [t25I]anti-anticasein of serum B, analyzed on polyacrylamide gel, showed 
molecular weight bands characteristic of heavy and light chains. 
In murine studies,  anti-idiotypic antibodies  induced  by hyperimmunization with 
antibody can be nearly 100% inhibited from binding to idiotype by antigen, whereas 
similar antibodies raised by immunization with antigen antibody complexes are ~75% 
blocked by antigen  (5, 24), indicating that the degree of saturation of antibody with 716  AUTOLOGOUS ANTI-IDIOTYPIC ANTIBODIES IN HUMAN SERA 
antigen  probably  dictates  the  ultimate  production of "site directed" vs.  "non-site 
directed" anti-idiotype (5,  24).  Because IgA-deficient humans  have an intermittent 
saturation of anticasein antibody with ingested antigen (3), it is most interesting that 
the degree of antigen inhibition found in subjects A and B (80, 95%) falls between the 
levels found in  murine studies  for immunization  with  antibody alone  (100%)  and 
immunization with antigen-antibody complexes (75%). 
The interactions between anticasein, anti-anticasein, and casein were tested in two 
systems, one using anti-anticasein bound to SA and another using anticasein bound 
to polystyrene. The anticasein of subject B could inhibit by 43% the binding of subject 
A's  anticasein  to  anti-anticasein;  in  an  inverse experiment,  subject  A's  anticasein 
could inhibit the same reaction of subject B by 34%. Whereas these data may suggest 
that some of the anticaseins of these individuals could share certain idiotypic deter- 
minants, such cross reactivities are not held conclusive unless -->50% inhibition can be 
demonstrated (25). Although unusual except in families (26), cross-idiotypic reactivi- 
ties have previously been detected between monoclonal IgG and  IgM  rheumatoid 
factors  (RF)  (27),  polyelonal  IgM  RF  (27),  cold  agglutinins  (28),  and  anti-Rh 
antibodies  of unrelated  individuals  (29).  However, it  is possible that  IgA-deficient 
subjects,  who  already  share  a  particular  defect  of heavy  chain  immunoglobulin 
synthesis, could also share V-region restrictions that limit idiotypic expression, in that 
the expression of V  region and immunoglobulin regions appears to be closely linked 
genetically. 
These experiments suggest  that  the binding of anti-idiotype into the circulating 
immune  complexes  of an  IgA-deficient  individual  could  be  dependent  upon  the 
content of antigen in these complexes. Because IgA-deficient individuals often have 
markedly  increased  antibody  titers  to  bovine  gamma  globulin,  a-laetalbumin, 
fl-lactoglobulin and ovalbumin, in addition to casein (3, 30), it is probable that anti- 
idiotypic antibodies corresponding to each of these antibodies are produced, and one 
might expect that the circulating complexes so frequently present in the sera of these 
individuals  could  contain  continuously  fluctuating  amounts  of antigen  and  anti- 
idiotype, depending on diet. A possible model scheme of these interactions is shown 
in Fig.  3. This model satisfies our previous observations that  IgA-deficient subjects 
can  have  high  levels of complexes even  after an  overnight  fast,  which  often  falls 
sharply after ingesting bovine milk (3). Although these could be complexes containing 
antigen  y 
~>---ontlbody,  ~  onti-ldlotype 
Fxo. 3.  When fasting, the immune complexes of an  IgA-deficient subject are predominantly 
composed of idiotype  and anti-idiotype.  As dietary antigen enters the blood stream, anti-idiotype  is 
largely displaced by antigen, but as antigen concentrations are reduced, the immune complexes 
contain both idiotype and antigen. Eventually, as antigen disappears, the original balance of 
idiotype-anti-idiotype  complex  is restored. CHARLOTTE CUNNINGHAM-RUNDLES  717 
long-lived dietary antigens, it is equally probable, in view of the experiments reported 
here, that these are antibody-anti-idiotype complexes. In either case, the quantitative 
level of immune  complex would  be expected to be diminished  by the addition  of 
increasing amounts of a  relevant antigen since smaller molecular weight complexes 
are less effectively bound to Raji cells (31). 
The ultimate immunologic effect produced in these individuals by the continuous 
production of idiotype and anti-idiotype is a  critical issue.  In murine studies, anti- 
idiotypes have been found to be capable of suppressing the expression of idiotypes 
(32, 33) and may, in other systems, replace antigen as a trigger to idiotype production 
(34).  In  addition,  both  idiotype  (35)  and  anti-idiotype  (36)  have  been  found  to 
generate suppressor T  cell activity in murine studies. It has, however, been uncertain 
to what  degree murine experiments could be expected to elucidate human  mecha- 
nisms. The experiments described here provide evidence of a  naturally existing and 
unique model that may be used to explore these questions in human studies. 
Summary 
50% of individuals with selective IgA deficiency have high serum titers of antibody 
to bovine proteins,  and  high  levels of circulating immune complexes that  contain 
bovine  antigens.  Because  in  animal  studies,  immunization  with  antigen-antibody 
complexes is a very effective means of producing anti-idiotypic antibodies, we sought 
such autoantibodies in two sera known to have large amounts of anticasein. After IgG 
isolation and two-stage affinity chromatography, IgG-like material (molecular weights 
of H  and L chains on SDS-PAGE), with binding activity for the F(ab')2 of anticasein 
were  isolated  from  both  sera.  Pooled  human  gamma  globulin  or  IgG  myeloma 
proteins  did  not  inhibit  binding  of specific anti-anticaseins  to  the  corresponding 
anticasein, but sodium caseinate did block this binding (by 80 and 95%) indicating 
that most of these autoantibodies have affinity for the casein-binding site. Naturally 
occurring anti-idiotypic antibodies have been difficult to conclusively demonstrate in 
human  sera;  consequently, these experiments provide evidence of a  unique  model 
which may be used to explore the network theory of immunoglobulin regulation in 
humans. 
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